Systematic Financial Management LP decreased its position in Chemed Corp. (NYSE:CHE) by 18.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 8,695 shares of the company’s stock after selling 1,935 shares during the quarter. Systematic Financial Management LP owned about 0.05% of Chemed Corp. worth $1,778,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in CHE. BlackRock Inc. raised its stake in Chemed Corp. by 145,760.9% in the 1st quarter. BlackRock Inc. now owns 1,955,994 shares of the company’s stock valued at $357,341,000 after purchasing an additional 1,954,653 shares during the last quarter. Vanguard Group Inc. raised its stake in Chemed Corp. by 7.5% in the 1st quarter. Vanguard Group Inc. now owns 1,795,773 shares of the company’s stock valued at $328,070,000 after purchasing an additional 125,018 shares during the last quarter. State Street Corp raised its stake in Chemed Corp. by 9.1% in the 1st quarter. State Street Corp now owns 445,367 shares of the company’s stock valued at $81,370,000 after purchasing an additional 37,085 shares during the last quarter. Old Mutual Global Investors UK Ltd. raised its stake in Chemed Corp. by 672.6% in the 2nd quarter. Old Mutual Global Investors UK Ltd. now owns 34,813 shares of the company’s stock valued at $7,120,000 after purchasing an additional 30,307 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in Chemed Corp. by 45.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 86,314 shares of the company’s stock valued at $17,653,000 after purchasing an additional 27,027 shares during the last quarter. 96.96% of the stock is owned by hedge funds and other institutional investors.

Chemed Corp. (NYSE:CHE) opened at 193.32 on Friday. The company has a 50-day moving average of $193.87 and a 200 day moving average of $195.60. The firm has a market cap of $3.09 billion, a P/E ratio of 47.96 and a beta of 1.14. Chemed Corp. has a 52 week low of $132.92 and a 52 week high of $216.01.

Chemed Corp. (NYSE:CHE) last released its quarterly earnings results on Tuesday, July 25th. The company reported $2.15 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.89 by $0.26. Chemed Corp. had a return on equity of 26.18% and a net margin of 4.16%. The business had revenue of $415.06 million during the quarter, compared to analyst estimates of $407.56 million. During the same quarter last year, the company posted $1.80 EPS. Chemed Corp.’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, equities analysts predict that Chemed Corp. will post $8.21 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, September 1st. Investors of record on Monday, August 14th were given a $0.28 dividend. This is a positive change from Chemed Corp.’s previous quarterly dividend of $0.26. The ex-dividend date of this dividend was Thursday, August 10th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.58%. Chemed Corp.’s dividend payout ratio (DPR) is 28.07%.

TRADEMARK VIOLATION WARNING: “Systematic Financial Management LP Cuts Stake in Chemed Corp. (CHE)” was first reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/09/15/systematic-financial-management-lp-cuts-stake-in-chemed-corp-che.html.

In related news, insider Kevin J. Mcnamara sold 15,000 shares of the stock in a transaction dated Friday, July 28th. The stock was sold at an average price of $201.16, for a total value of $3,017,400.00. Following the completion of the sale, the insider now directly owns 173,801 shares of the company’s stock, valued at approximately $34,961,809.16. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Spencer S. Lee sold 1,000 shares of the stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $197.46, for a total value of $197,460.00. Following the completion of the sale, the insider now directly owns 37,809 shares of the company’s stock, valued at $7,465,765.14. The disclosure for this sale can be found here. Company insiders own 5.32% of the company’s stock.

CHE has been the subject of several analyst reports. BidaskClub downgraded shares of Chemed Corp. from a “strong-buy” rating to a “buy” rating in a research note on Thursday, June 22nd. Oppenheimer Holdings, Inc. boosted their target price on shares of Chemed Corp. from $200.00 to $220.00 and gave the company an “outperform” rating in a research note on Thursday, July 27th. Zacks Investment Research raised shares of Chemed Corp. from a “hold” rating to a “buy” rating and set a $226.00 target price for the company in a research note on Friday, July 28th. Royal Bank Of Canada reissued a “hold” rating and issued a $208.00 target price on shares of Chemed Corp. in a research note on Wednesday, July 5th. Finally, TheStreet downgraded shares of Chemed Corp. from a “b+” rating to a “c+” rating in a research note on Tuesday, July 25th. Three investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $214.00.

About Chemed Corp.

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed Corp. (NYSE:CHE)

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.